Repurposing of an antiasthmatic drug may reduce NETosis and myocardial ischaemia/reperfusion injury

Eur Heart J. 2024 May 13;45(18):1681-1683. doi: 10.1093/eurheartj/ehae201.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Asthmatic Agents / pharmacology
  • Anti-Asthmatic Agents / therapeutic use
  • Drug Repositioning*
  • Extracellular Traps / drug effects
  • Humans
  • Myocardial Reperfusion Injury* / drug therapy
  • Myocardial Reperfusion Injury* / prevention & control

Substances

  • Anti-Asthmatic Agents